Slovenia's pharma giant greenlights final dividend
The shareholders of the Ljubljana-based pharmaceutical and medical equipment wholesaler Salus approved a dividend proposal at the annual general meeting (AGM).
A total of EUR 8.43 million will be allocated for dividends, CE Report quotes STA.
This translates to EUR 80 gross per share.
The amount includes an interim dividend of EUR 40 gross per share that was already paid out in January.
